Nektar Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapies that selectively modulate the immune system to treat serious and widespread unmet medical needs. They have a robust R&D pipeline of investigational medicines in oncology, immunology, and other therapeutic areas.
Focus Areas
Notable Investments
